Mesoblast
MESO
34 hedge funds and large institutions have $11.1M invested in Mesoblast in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
21% more funds holding
Funds holding: 28 → 34 (+6)
0.02% more ownership
Funds ownership: 0.21% → 0.23% (+0.02%)
31% less capital invested
Capital invested by funds: $16.1M → $11.1M (-$4.96M)
96% less call options, than puts
Call options by funds: $11K | Put options by funds: $282K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.11M |
| 2 |
Millennium Management
New York
|
+$313K |
| 3 |
Morgan Stanley
New York
|
+$274K |
| 4 |
WSTAM
Wilbanks Smith & Thomas Asset Management
Norfolk,
Virginia
|
+$214K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$200K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MGIM
M&G Investment Management
London,
United Kingdom
|
-$544K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$323K |
| 3 |
Jane Street
New York
|
-$60K |
| 4 |
PM
Penbrook Management
New York
|
-$25.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$16K |
MESO Hedge Fund Activity: Q1 2020 in Review
34 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q1 2020, worth a combined $11.1M — down 31% from $16.1M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new MESO positions and 5 closed out — a net gain of 7 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.11M. The largest seller was M&G Investment Management, cutting an estimated $544K.
- 34 institutional investors held Mesoblast (MESO) as of Q1 2020, up from 28 in Q4 2019.
- Funds reported $11.1M of Mesoblast stock for Q1 2020, down 31% quarter-over-quarter.
- 12 funds opened new Mesoblast positions in Q1 2020 and 5 closed out, a net change of +7 holders.
- The largest Mesoblast buyer in Q1 2020 was Renaissance Technologies, an estimated $1.11M added.
- The largest Mesoblast seller in Q1 2020 was M&G Investment Management, an estimated $544K sold.
Based on aggregated 13F filings for Q1 2020.